Pharming Group NV (PHAR)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.93B
EV to revenue ratio (TTM)
2.07
EV to ebitda
19.83
Financial Performance
Revenue (TTM)
$0.39B
Gross profit (TTM)
$0.34B
EBITDA
$0.06B
Profitability
Operating margin (TTM)
33.90%
Profit margin
6.25%
Return on assets (TTM)
6.37%
Return on equity (TTM)
8.70%
Per Share Metrics
Revenue per share (TTM)
$5.17
EPS
$0.32
Diluted EPS (TTM)
$0.32
Book value
$4.26
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
41.12
Trailing P/E
41.12
Forward P/E
243.90
PEG ratio
n/a
Price to sales ratio (TTM)
2.41
Price to book ratio (TTM)
2.99
Growth
Quarterly earnings growth (YoY)
20.80%
Quarterly revenue growth (YoY)
74.90%
Analyst Sentiment
Strong buy
0
Buy
4
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.05